Abstract
Heat shock proteins (HSPs) are a group of proteins that promote protein folding, inhibit denaturation of cellular proteins, and maintain other proteins’ functional activities when cells are subjected to stress and/or high temperature. HSP classification is generally based on their molecular weights into large and small HSP. The family of small HSPs includes HSPs 27, 40, 60, 70, and 90. The potential roles of HSP27 and HSP70 are quite evident in different solid malignancies, including breast, colorectal, pancreatic, and liver cancers. In this chapter, the authors focus on HSP27 and HSP70 signaling in oncology and their role in different solid malignancies as well as they shed light on the novel role of HSP70 and HSP90 in the immune-oncology field.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Abbreviations
- AAD:
-
Apoptosis activation domain
- AIF:
-
Apoptosis-inducing factor
- Apaf-1 :
-
Apoptotic protease-activating factor 1
- APC:
-
Antigen-presenting cells
- Ask1:
-
Apoptosis signal-regulating kinase 1
- BID:
-
BH3 interacting-domain death agonist
- BT-474:
-
Human breast tumor cell line
- CARD:
-
Caspase-recruitment domain
- CDK4:
-
Cyclin-dependent kinase 4
- Clever:
-
Common lymphatic endothelial and vascular endothelial receptor
- CRC:
-
Colorectal cancer
- Daxx:
-
Death domain-associated protein 6
- DEN:
-
Diethylnitrosamine
- DR:
-
Death receptor
- EMT:
-
Epithelial to mesenchymal transition
- ER:
-
Endoplasmic reticulum
- FADD:
-
Fas-associated death domain
- FBD:
-
Fas binding domain
- GADD153:
-
Growth arrest and DNA damage-inducible gene 153
- GRP:
-
Glucose-related protein
- HCC:
-
Hepatocellular carcinoma
- HER-2:
-
Human epidermal growth factor 2
- HSF:
-
Heat shock factor
- HSP:
-
Heat shock protein
- HUGO:
-
Human genome organisation
- JNK:
-
C-Jun N-terminal kinase
- LOX-1:
-
Low-density lipoprotein receptor-1
- MDS:
-
Myelodysplastic syndrome
- MHC:
-
Major histocompatibility complex
- NY-ESO-1:
-
New York-esophageal
- PES:
-
Phenylethynesulfonamide
- PHC:
-
Primary hepatocellular carcinoma
- PKC:
-
Protein kinase C
- PTEN:
-
Phosphatase and tensin homolog
- SPAG9:
-
Sperm-associated antigen 9 protein
- SREC-1:
-
Scavenger receptor expressed by endothelial cell 1
- SUMO:
-
Small ubiquitin-like modifier
- TNF:
-
Tumor necrosis factor
- VEGF:
-
Vascular endothelial growth factor
- WT:
-
Wild type
References
Cayado-Gutierrez N et al (2013) Downregulation of Hsp27 (HSPB1) in MCF-7 human breast cancer cells induces upregulation of PTEN. Cell Stress Chaperones 18(2):243–249
Chakafana G, Zininga T, Shonhai A (2019) The link that binds: the linker of Hsp70 as a helm of the protein’s function. Biomol Ther 9(10)
Chang HY et al (1998) Activation of apoptosis signal-regulating kinase 1 (ASK1) by the adapter protein Daxx. Science 281(5384):1860–1863
Charette SJ, Landry J (2000) The interaction of HSP27 with Daxx identifies a potential regulatory role of HSP27 in Fas-induced apoptosis. Ann N Y Acad Sci 926:126–131
Chatterjee S, Burns TF (2017) Targeting heat shock proteins in cancer: a promising therapeutic approach. Int J Mol Sci 18(9)
Cho W et al (2019) The molecular chaperone heat shock protein 70 controls liver cancer initiation and progression by regulating adaptive DNA damage and mitogen-activated protein kinase/extracellular signal-regulated kinase signaling pathways. Mol Cell Biol 39(9)
Choi S-K et al (2019) Targeting heat shock protein 27 in cancer: a druggable target for cancer treatment? Cancers 11(8):1195
Chuma M et al (2003) Expression profiling in multistage hepatocarcinogenesis: identification of HSP70 as a molecular marker of early hepatocellular carcinoma. Hepatology 37(1):198–207
Ciocca DR, Calderwood SK (2005) Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 10(2):86–103
Cruz FM et al (2017) The biology and underlying mechanisms of cross-presentation of exogenous antigens on MHC-I molecules. Annu Rev Immunol 35:149–176
Das JK et al (2019) Heat shock proteins in cancer immunotherapy. J Oncol 2019:3267207
Eto D et al (2016) Expression of HSP27 in hepatocellular carcinoma. Anticancer Res 36(7):3775–3779
Garrido C et al (1999) HSP27 inhibits cytochrome c-dependent activation of procaspase-9. FASEB J 13(14):2061–2070
Ge H et al (2017) SUMOylation of HSP27 by small ubiquitin-like modifier 2/3 promotes proliferation and invasion of hepatocellular carcinoma cells. Cancer Biol Ther 18(8):552–559
Gotoh T et al (2004) hsp70-DnaJ chaperone pair prevents nitric oxide- and CHOP-induced apoptosis by inhibiting translocation of Bax to mitochondria. Cell Death Differ 11(4):390–402
Gross C et al (2003) Interaction of heat shock protein 70 peptide with NK cells involves the NK receptor CD94. Biol Chem 384(2):267–279
Han Z-J et al (2018) The post-translational modification, SUMOylation, and cancer (review). Int J Oncol 52(4):1081–1094
Hayashi N et al (2012) Hsp27 silencing coordinately inhibits proliferation and promotes Fas-induced apoptosis by regulating the PEA-15 molecular switch. Cell Death Differ 19(6):990–1002
Huang CY et al (2018) Silencing heat shock protein 27 inhibits the progression and metastasis of colorectal cancer (CRC) by maintaining the stability of stromal interaction molecule 1 (STIM1) proteins. Cell 7(12)
Jaattela M (1995) Over-expression of hsp70 confers tumorigenicity to mouse fibrosarcoma cells. Int J Cancer 60(5):689–693
Jagadish N et al (2016a) Heat shock protein 70-2 (HSP70-2) overexpression in breast cancer. J Exp Clin Cancer Res 35(1):150
Jagadish N et al (2016b) Heat shock protein 70-2 (HSP70-2) is a novel therapeutic target for colorectal cancer and is associated with tumor growth. BMC Cancer 16:561–561
Kampinga HH et al (2009) Guidelines for the nomenclature of the human heat shock proteins. Cell Stress Chaperones 14(1):105–111
Kang SH et al (2008) Upregulated HSP27 in human breast cancer cells reduces Herceptin susceptibility by increasing Her2 protein stability. BMC Cancer 8:286
Kasioumi P et al (2019) Hsp70 (HSP70A1A) downregulation enhances the metastatic ability of cancer cells. Int J Oncol 54(3):821–832
Kim EH et al (2007) Inhibition of heat shock protein 27-mediated resistance to DNA damaging agents by a novel PKC delta-V5 heptapeptide. Cancer Res 67(13):6333–6341
Krajarng A et al (2015) Apoptosis induction associated with the ER stress response through up-regulation of JNK in HeLa cells by gambogic acid. BMC Complement Altern Med 15(1):26
Leu JI et al (2011) HSP70 inhibition by the small-molecule 2-phenylethynesulfonamide impairs protein clearance pathways in tumor cells. Mol Cancer Res 9(7):936–947
Malusecka E et al (2001) Expression of heat shock proteins HSP70 and HSP27 in primary non-small cell lung carcinomas. An immunohistochemical study. Anticancer Res 21(2a):1015–1021
Massey AJ et al (2010) A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells. Cancer Chemother Pharmacol 66(3):535–545
Meng L et al (2011) Heat shock protein Hsp72 plays an essential role in Her2-induced mammary tumorigenesis. Oncogene 30(25):2836–2845
Miller DJ, Fort PE (2018) Heat shock proteins regulatory role in neurodevelopment. Front Neurosci 12:821
Murphy ME (2013) The HSP70 family and cancer. Carcinogenesis 34(6):1181–1188
Murshid A, Gong J, Calderwood SK (2012) The role of heat shock proteins in antigen cross presentation. Front Immunol 3:63–63
Parcellier A et al (2003) HSP27 is a ubiquitin-binding protein involved in I-kappaBalpha proteasomal degradation. Mol Cell Biol 23(16):5790–5802
Pardue ML, Bendena WG, Garbe JC (1987) Heat shock: puffs and response to environmental stress. Results Probl Cell Differ 14:121–131
Rahmoon MA et al (2017) MiR-615-5p depresses natural killer cells cytotoxicity through repressing IGF-1R in hepatocellular carcinoma patients. Growth Factors 35(2–3):76–87
Saleh A et al (2000) Negative regulation of the Apaf-1 apoptosome by Hsp70. Nat Cell Biol 2(8):476–483
Saluja A, Dudeja V (2008) Heat shock proteins in pancreatic diseases. J Gastroenterol Hepatol 23(Suppl 1):S42–S45
Seo JS et al (1996) T cell lymphoma in transgenic mice expressing the human Hsp70 gene. Biochem Biophys Res Commun 218(2):582–587
Shevtsov M, Multhoff G (2016) Heat shock protein-peptide and HSP-based immunotherapies for the treatment of cancer. Front Immunol 7:171–171
Sliutz G et al (1996) Drug resistance against gemcitabine and topotecan mediated by constitutive hsp70 overexpression in vitro: implication of quercetin as sensitiser in chemotherapy. Br J Cancer 74(2):172–177
Specht HM et al (2015) Heat shock protein 70 (Hsp70) peptide activated natural killer (NK) cells for the treatment of patients with non-small cell lung cancer (NSCLC) after radiochemotherapy (RCTx) – from preclinical studies to a clinical phase II trial. Front Immunol 6:162
Taba K et al (2010) Heat-shock protein 27 is phosphorylated in gemcitabine-resistant pancreatic cancer cells. Anticancer Res 30(7):2539–2543
Takakuwa JE et al (2019) Oligomerization of Hsp70: current perspectives on regulation and function. Front Mol Biosci 6:81
Wang RE et al (2009) Inhibition of heat shock induction of heat shock protein 70 and enhancement of heat shock protein 27 phosphorylation by quercetin derivatives. J Med Chem 52(7):1912–1921
Wei L et al (2011) Hsp27 participates in the maintenance of breast cancer stem cells through regulation of epithelial-mesenchymal transition and nuclear factor-kappaB. Breast Cancer Res 13(5):R101
Westerheide SD et al (2006) Triptolide, an inhibitor of the human heat shock response that enhances stress-induced cell death. J Biol Chem 281(14):9616–9622
Wu J et al (2017) Heat shock proteins and cancer. Trends Pharmacol Sci 38(3):226–256
Xia Y et al (2012) Targeting heat shock response pathways to treat pancreatic cancer. Drug Discov Today 17(1):35–43
Yang Y et al (2019) MiR-214 sensitizes human colon cancer cells to 5-FU by targeting Hsp27. Cell Mol Biol Lett 24:22
Youness RA et al (2016) Contradicting interplay between insulin-like growth factor-1 and miR-486-5p in primary NK cells and hepatoma cell lines with a contemporary inhibitory impact on HCC tumor progression. Growth Factors 34(3–4):128–140
Yun CW et al (2019) Heat shock proteins: agents of cancer development and therapeutic targets in anti-cancer therapy. Cell 9(1)
Zaimoku R et al (2019) Monitoring of heat shock response and phenotypic changes in hepatocellular carcinoma after heat treatment. Anticancer Res 39(10):5393–5401
Zhang S et al (2015) The effects of HSP27 on gemcitabine-resistant pancreatic cancer cell line through snail. Pancreas 44(7):1121–1129
Acknowledgments
Not available.
Conflict of Interest
All authors declare they have no conflict of interest.
Ethical Approval for Studies Involving Humans
This article does not contain any studies with human participants performed by any of the authors.
Ethical Approval for Studies Involving Animals
This article does not contain any studies with animals performed by any of the authors.
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Youness, R.A., Gohar, A., Kiriacos, C.J., El-Shazly, M. (2022). Heat Shock Proteins: Central Players in Oncological and Immuno-Oncological Tracks. In: Turksen, K. (eds) Cell Biology and Translational Medicine, Volume 18. Advances in Experimental Medicine and Biology(), vol 1409. Springer, Cham. https://doi.org/10.1007/5584_2022_736
Download citation
DOI: https://doi.org/10.1007/5584_2022_736
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-28423-6
Online ISBN: 978-3-031-28424-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)